Cefiderocol: a first and novel class of siderophore cephalosporin for Carbapenem-resistant Gram-negative infection
Folia Pharmacologica Japonica · 2024
DOI: 10.1254/fpj.24029 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Folia Pharmacologica Japonica, 2024. Verfasst von Yoshinori Yamano und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Drug Discovery and Disease Research, Shionogi & Co., Ltd. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Carbapenems, Cefiderocol, Cephalosporins. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory for Drug Discovery and Disease Research, Shionogi & Co., Ltd.
- Medical Affairs Department, Shionogi & Co., Ltd.
- Drug Development and Regulatory Science Division, Shionogi & Co., Ltd.
Zitieren
APA
Yamano, Y., Morita, I., & Ariyasu, M. (2024). Cefiderocol: a first and novel class of siderophore cephalosporin for Carbapenem-resistant Gram-negative infection. Folia Pharmacologica Japonica. https://doi.org/10.1254/fpj.24029
Vancouver
Yamano Y, Morita I, Ariyasu M. Cefiderocol: a first and novel class of siderophore cephalosporin for Carbapenem-resistant Gram-negative infection. Folia Pharmacologica Japonica. 2024. doi:10.1254/fpj.24029
BibTeX
@article{Yamano2024,
author = {Yamano, Yoshinori and Morita, Ippei and Ariyasu, Mari},
title = {Cefiderocol: a first and novel class of siderophore cephalosporin for Carbapenem-resistant Gram-negative infection},
journal = {Folia Pharmacologica Japonica},
year = {2024},
doi = {10.1254/fpj.24029}
}
EUVIMED